Ten-day decitabine with venetoclax (DEC10-VEN) in AML and high-risk (HR) MDS.

Maiti, A; Dinardo, CD; Pemmaraju, N; Kadia, TM; Rausch, CR; Naqvi, K; Daver, NG; Borthakur, G; Ohanian, M; Issa, GC; Alvarado, Y; Short, NJ; Andreeff, M; Jabbour, E; Pierce, SA; Ravandi, F; Garcia-Manero, G; Welch, JS; Kantarjian, HM; Konopleva, M

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):